Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Stephen Feinberg Buys More Shares Of Pacific DataVision (PDVW)

Page 1 of 2

Stephen Feinberg just cannot keep his hands off of Pacific DataVision Inc (NASDAQ:PDVW)‘s shares. In its latest filing with the Securities and Exchange Commission, Feinberg and his fund, Cerberus Capital Management, have reported another increase to their stake in the company, of 38,917 shares at prices varying between $31.49 and $31.96 per share, lifting its holding to 3.29 million shares or 23.1% of the company’s common stock. So, why has he gone on this buying spree?


Founded in 1992 by Feinberg and William Richter, currently a senior managing director at the fund, Cerberus Capital Management has grown to control more than $25 billion in assets. The fund’s public equity portfolio carries a market value of $1.36 billion spread between ten stocks, most of them from the finance industry. Feinberg’s biggest bet continues to be in Ally Financial Inc (NYSE:ALLY), with Cerberus holding 41.5 million shares valued at $931 million, according to the fund’s latest 13F filing. Its second-biggest investment and also a new addition to its portfolio during the second quarter is American Capital Agency Corp. (NASDAQ:AGNC). Feinberg built a position that comprises 9.66 million shares valued at $177 million as of June 30.

Stephen Feinberg
Stephen Feinberg
Cerberus Capital Management

Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned 118% over the ensuing 35 months, outperforming the S&P 500 Index by over 60 percentage points (read the details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!